Well, since then a lot has happened, and I have read quite a number of positive studies on aspirin and cancer, so I am taking this opportunity to revise my former position, without going overboard, of course (no stuffing my face with aspirin every single night, I mean!). Proceed with caution, as always, since aspirin does have some side effects… Anyway, here goes.
A 2014 study, titled “Regular aspirin use and risk of multiple myeloma: a prospective analysis in the health professionals follow-up study and nurses’ health study,” suggests that aspirin might be beneficial to myeloma patients. To see the study, click on this link: goo.gl/P0su2f
Interesting excerpt: “Participants with a cumulative average of ?5 adult strength (325 mg) tablets per week had a 39% lower multiple myeloma risk than nonusers […].”
A 39% lower risk? Wowsie.
I was actually reminded of this issue earlier today, when I happened upon an intriguing Scientific American (May 2017 issue) article on aspirin and cancer, Among other things, the article discusses aspirin’s apparent interference “with the ability of cancer cells to spread, or metastasize, through the body.” It’s is an easy read and so, without further ado, here is the link: goo.gl/uAhwv2
But wow, aspirin may prevent metastasis…and it may be beneficial to myeloma patients…two articles and one stone…Not too shabby, eh?